Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (51-60 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Oncotarget|November 27, 2016
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapseLindi Chen, Angharad Humphreys, Lisa Turnbull, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastomaQiwei Yang, Peter Zage, David Kagan, et al.
Epigenetics|August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxiaAnastasia E Hains, Sakshi Uppal, John Z Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastomaMichelle Haber, Janice Smith, Sharon B Bordow, et al.
BMC Cancer|June 16, 2010
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell linesQiwei Yang, Yufeng Tian, Kelly R Ostler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcomeQiwei Yang, Colleen M Kiernan, Yufeng Tian, et al.
Cancer Research|July 3, 2004
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastomaQiwei Yang, Shuqing Liu, Yufeng Tian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Pageof 19

Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Oncotarget|November 27, 2016
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapseLindi Chen, Angharad Humphreys, Lisa Turnbull, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastomaQiwei Yang, Peter Zage, David Kagan, et al.
Epigenetics|August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxiaAnastasia E Hains, Sakshi Uppal, John Z Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastomaMichelle Haber, Janice Smith, Sharon B Bordow, et al.
BMC Cancer|June 16, 2010
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell linesQiwei Yang, Yufeng Tian, Kelly R Ostler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcomeQiwei Yang, Colleen M Kiernan, Yufeng Tian, et al.
Cancer Research|July 3, 2004
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastomaQiwei Yang, Shuqing Liu, Yufeng Tian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Pageof 19